The big unknown is whether CDMO capacity built for branded drugs gets diverted to generics, and whether SPPS can scale fast ...

The MarketWatch News Department was not involved in the creation of this content. The global industry was valued at US$ 38.9 Bn in 2022 and is expected to register a CAGR of 7.1% from 2023 to 2031.

API scale-up success relies on choosing routes that balance efficiency, robustness, and manufacturability across development ...

Goldman Sachs reports the future of semaglutide genericisation and GLP-1 pricing hinges on peptide API manufacturing capacity ...

Dublin, April 30, 2026 (GLOBE NEWSWIRE)-- The "Pharmaceutical API Manufacturing Market Report 2026" has been added to ResearchAndMarkets.com's offering. The pharmaceutical API manufacturing market has ...

MISSISSAUGA, Ontario, April 16, 2026--(BUSINESS WIRE)--Eurofins CDMO Alphora is excited to announce the expansion of its Active Pharmaceutical Ingredient (API) manufacturing capabilities through the ...

LONGMONT, Colo.--(BUSINESS WIRE)--Avista Pharma Solutions, Inc. (“Avista Pharma”) has completed facility upgrades that effectively double the company’s API manufacturing capacity at its Longmont, ...

BEIJING--(BUSINESS WIRE)--Pharmaron Beijing Co., Limited (Stock Code: 300759.SZ/3759.HK) (“Pharmaron”) announced today that it has acquired Aesica Pharmaceuticals Limited (“The Cramlington Site”) from ...

Amazon Filters is a leading manufacturer of bespoke filter housings and high-performance filter media used in the manufacture of Active Pharmaceutical Ingredients (API's) - vital building blocks for ...

HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...